C

CARsgen Therapeutics Holdings
2171

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
HK$8.63B
EV
HK$7.24B
Shares Outstanding
559.97M
Beta
0.39

Wall Street View

Analyst Rating
UNDERPERFORM
Analyst Target Price
HK$8.43
P/E 2025E
-
P/Revenue 2025E
88.70x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About CARsgen Therapeutics Holdings Limited

gainify

C

CARsgen Therapeutics Holdings Limited

2171

CARsgen Therapeutics Holdings Limited, an investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United St...

Sector

Healthcare

Industry

Biotechnology

CEO

Li, Zonghai

Employees

465

IPO Date

2021-06-18

Headquarters

No. 466 Yindu Road, 1st Floor, Building 2, Xuhui District, Shanghai China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved